Long-term safety experience of ustekinumab in patients with moderate-to-severe psoriasis (Part I of II): Results from analyses of general safety parameters from pooled Phase 2 and 3 clinical trials-Reference-Cited by-同舟云学术

Long-term safety experience of ustekinumab in patients with moderate-to-severe psoriasis (Part I of II): Results from analyses of general safety parameters from pooled Phase 2 and 3 clinical trials

Published:2012-05 Issue:5 Volume:66 Page:731-741
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Lebwohl Mark,Leonardi Craig,Griffiths Christopher E.M.,Prinz Jörg C.,Szapary Philippe O.,Yeilding Newman,Guzzo Cynthia,Li Shu,Hsu Ming-Chun,Strober Bruce

Publisher

Elsevier BV

Subject

Dermatology

Reference34 articles.

1. Etanercept as monotherapy in patients with psoriasis;Leonardi;N Engl J Med,2003

2. A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction;Papp;Br J Dermatol,2005

3. Etanercept monotherapy in patients with psoriasis: a summary of safety, based on an integrated multistudy database;Gottlieb;J Am Acad Dermatol,2006

4. Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes;Ellis;N Engl J Med,2001

5. A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis;Krueger;J Am Acad Dermatol,2002

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ustekinumab: In Psoriasis and Beyond —A Derm atological Perspective;Journal of Pharmacology and Pharmacotherapeutics;2024-05-08

2. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis;Cochrane Database of Systematic Reviews;2023-07-12

3. Exacerbation of Atopic Dermatitis Associated with Ustekinumab Treatment in Crohn's Disease;Cureus;2022-09-28

4. Actualización práctica de las recomendaciones del Grupo de Psoriasis de la Academia Española de Dermatología y Venereología (GPS) para el tratamiento de la psoriasis con terapia biológica. Parte 2 «Manejo de poblaciones especiales, pacientes con comorbilidad y gestión del riesgo»;Actas Dermo-Sifiliográficas;2022-06

5. [Translated article] Practical Update of the Guidelines Published by the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (GPs) on the Treatment of Psoriasis With Biologic Agents: Part 2—Management of Special Populations, Patients With Comorbid Conditions, and Risk;Actas Dermo-Sifiliográficas;2022-06